innovation
A step closer to understanding our immune system to improve therapies for chronic inflammatory diseases
The Institut Pasteur, in collaboration with Johnson & Johnson Innovative Medicine Research & Development, uncovers the interactions between a molecule (the cytokine interleukine-23 (IL-23)) produced by the immune system and so-called mucosal-associated invariant T (MAIT) cells, which are involved early in the immune response to fight pathogens.